期刊文献+

HPLC法测定注射用头孢哌酮钠、他唑巴坦钠中两组分的含量和有关物质 被引量:9

HPLC Determination of Two Components and Related Substances in Cefoperazone Sodium and Tazobactam Sodium for Injection
暂未订购
导出
摘要 目的:用 HPLC 法测定注射用头孢哌酮钠他唑巴坦钠中头孢哌酮和他唑巴坦的含量及其有关物质。方法:用 ZorbaxSB-C_(18)色谱柱(4.6/mm/×250mm,5μm);乙腈-0.03 mol·L^(-1)磷酸二氢钾溶液-10%四丁基氢氧化铵溶液(190:795:15)(用磷酸调 pH 为4.0)为流动相;检测波长:230nm;流速:1 mL·min^(-1);进样量:10 μL。柱温:30℃。结果:头孢哌酮与他唑巴坦分别与其相邻杂质峰能完全分离,头孢哌酮在14.96~2695.35μg·mL^(-1)、他唑巴坦在13.98~2796.8μg·mL^(-1)浓度范围内线性关系均良好,r 分别为0.9999和0.9993。结论:该法简便、准确、专属性好,可以用于注射用头孢哌酮钠他唑巴坦钠中头孢哌酮和他唑巴坦的含量测定及有关物质检查。 Objective:To establish the HPLC method for the determination of cefoperazone and tazobactam and its related substances in cefoperazone sodium and tazobactam sodium for injection. Methods:The HPLC system consisted of a Zorbax SB - C18 column(4. 6 mm ×250 mm,5 μm) and a mixture of acetonitrile -0. 03 mol · L^-1 potassium dihydrogen phosphate solution and 10% tetrabutyl ammonium hydroxide( 190: 795:15 ) as mobile phase. The flow rate was 1.0 mL ·min^- 1 with detection wavelength at 230 nm and column temperature at 30 ℃. Results:Cefoperazone and tazobactam could be completely separated from other impurities. The linear range of cefoperazone was 14. 96 -2695.35μg · mL^-1 (r =0. 9999) and tazobactam was 13.98 -2796. 8 μg · mL^-1 (r =0. 9993). Conclusion :The method is simple,accurate and it is suitable for the determination of cefoperazone and tazobactam and related substances in cefoperazone sodium and tazobactam sodium for injection.
出处 《药物分析杂志》 CAS CSCD 北大核心 2005年第11期1364-1366,共3页 Chinese Journal of Pharmaceutical Analysis
关键词 头孢哌酮钠 他唑巴坦钠 有关物质 高效液相色谱法 cefoperazone sodium tazobactam sodium related substance HPLC
  • 相关文献

参考文献6

  • 1.ChP(中国药典).Vol Ⅱ(二部)[M].,2000.Appendix(附录)64.
  • 2WS-205(X-177)-99.SFDA Drug Standard[国家药品监督管理局药品标准(试行)].[S].,..
  • 3裴保香,谭次娥,孙效东,王睿,傅宏义,李玉柱.头孢哌酮的药物动力学及药效学[J].中国临床药学杂志,1998,7(5):211-214. 被引量:12
  • 4商澎,徐明达.血清和组织间液中头孢哌酮的高效液相色谱测定方法[J].药物分析杂志,1992,12(6):327-329. 被引量:9
  • 5Johnson CA, Kelloway JS, Tonelli A, et al. Single - dose pharmacokinetics of piperacillin and tazobactam in patients with renal disease.Clin Pharmacol Ther,1992,51 ( 1 ) :32.
  • 6Wise R, Logan M, Cooper M, et al. Pharmacokinetics and penetration of tazobactam administered alone and with piperacillin. Antimicrob Agents Chemother, 1992,36(6) : 1997.

二级参考文献2

共引文献37

同被引文献2169

引证文献9

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部